Login
Home / 4114.TWO : TWO
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Synmosa Biopharma Corporation

TWD 29.35 -$0.84 (-2.78%)
TWO · 15 Sep 2026 05:30 UTC
Previous Close
TWD 29.45
Day Range
TWD 29.3TWD 29.5
Year Range
TWD 27.55TWD 35.14
Market Cap
15.84B
AVG Volume
1.22M
Trailing/Forward PE
18.58/17.51
PEG ratio
-29.54
Dividend Yield
2.89%
Next Earnings Date
2026-11-18
Primary Exchange
Taipei ExchangeTW
Revenue (TWD)
0500M1B1.5B2B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (TWD)
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (TWD)
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (TWD)
0100M200M300M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (TWD)
-200M-100M0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (TWD)
00.20.40.624 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (TWD)
0200M400M600MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (TWD)
01B2B3B4BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
-1-0.500.5124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%20%40%60%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
0%1%2%3%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Dividends (TWD)
00.250.50.751Aug 17Aug 18Jul 19Jul 20Sep 21Jul 22Aug 23Aug 24Jul 25Jul 26
Book Value Per Share (TWD)
010203024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (TWD)
05B10B15B20B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
10152025med 18.87Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Free Cash Flow Yield
1%2%3%4%5%med 2.54%Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Sales
1.522.53med 2.34Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
EV/EBITDA
810121416med 12.67Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price/Operating Cashflow
10203040med 23.17Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Book
11.21.41.61.8med 1.47Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Synmosa Biopharma Corporation
4114.TWO
Stockpicker

Video analysis: 4114.TWO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.